{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:08:28Z","timestamp":1793916508639,"version":"4.8.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidsponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jisp.2016.10.023","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T09:45:46Z","timestamp":1505900746000},"page":"S38-S45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Replenishing Regulatory T Cells to Halt\u00a0Depigmentation in Vitiligo"],"prefix":"10.1016","volume":"18","author":[{"given":"I. Caroline","family":"Le Poole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikhar","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jisp.2016.10.023_bib97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.autrev.2004.07.004","article-title":"T cell tolerance and autoimmunity","volume":"3","author":"Abbas","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jisp.2016.10.023_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/2230-8229.128767","article-title":"Consanguinity pattern and heritability of Vitiligo in Arar, Saudi Arabia","volume":"21","author":"Alenizi","year":"2014","journal-title":"J\u00a0Family Community Med"},{"key":"10.1016\/j.jisp.2016.10.023_bib2","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1365-4632.2010.04514.x","article-title":"Beliefs and perceptions of Arab vitiligo patients regarding their condition","volume":"49","author":"AlGhamdi","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2012.07.007","article-title":"Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A\u00a0systematic review of the literature","volume":"12","author":"Antico","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jisp.2016.10.023_bib4","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1167\/iovs.15-16883","article-title":"Inhibition of noninfectious uveitis using intravenous administration of collagen II-specific type 1 regulatory T cells","volume":"56","author":"Asnagli","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jisp.2016.10.023_bib5","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar4567","article-title":"Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis","volume":"16","author":"Asnagli","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jisp.2016.10.023_bib6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/jid.2012.59","article-title":"\u03b1-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation","volume":"132","author":"Auriemma","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib7","first-page":"118","article-title":"Characteristics of vitiligo in Lagos, Nigeria","volume":"28","author":"Ayanlowo","year":"2009","journal-title":"West Afr J Med"},{"key":"10.1016\/j.jisp.2016.10.023_bib8","doi-asserted-by":"crossref","unstructured":"Bacchetta R, Barzaghi F, Roncarolo MG (2016). From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation [e-pub ahead of print]. Ann N Y Acad Sci 2016; http:\/\/dx.doi.org\/10.1111\/nyas.13011 (accessed 21 October 2016).","DOI":"10.1111\/nyas.13011"},{"key":"10.1016\/j.jisp.2016.10.023_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1042\/BST20150247","article-title":"Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?","volume":"44","author":"Boardman","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jisp.2016.10.023_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-4362.2000.00880.x","article-title":"Epidemiology of vitiligo in the French West Indies (Isle of Martinique)","volume":"39","author":"Boisseau-Garsaud","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib11","doi-asserted-by":"crossref","first-page":"e11726","DOI":"10.1371\/journal.pone.0011726","article-title":"Human antigen-specific regulatory T cells generated by T cell receptor gene transfer","volume":"5","author":"Brusko","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jisp.2016.10.023_bib12","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI44849","article-title":"Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma","volume":"121","author":"Byrne","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jisp.2016.10.023_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/jid.2013.540","article-title":"A\u00a0quantitative increase in regulatory T cells controls development of vitiligo","volume":"134","author":"Chatterjee","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00262-005-0699-9","article-title":"Regulatory T cells and tumor immunity","volume":"54","author":"Chattopadhyay","year":"2005","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jisp.2016.10.023_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.det.2005.05.007","article-title":"Stigma experience in skin disorders: an Indian perspective","volume":"23","author":"Chaturvedi","year":"2005","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jisp.2016.10.023_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2015011246","article-title":"Scaffolds. A novel carrier and potential wound healer","volume":"32","author":"Chaudhary","year":"2015","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.jisp.2016.10.023_bib17","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jisp.2016.10.023_bib18","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1002\/1521-4141(200212)32:12<3506::AID-IMMU3506>3.0.CO;2-#","article-title":"Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1\/I-309","volume":"32","author":"Colantonio","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib19","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2008.45","article-title":"HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo","volume":"128","author":"Denman","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.autrev.2014.10.002","article-title":"Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics","volume":"14","author":"Dwivedi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jisp.2016.10.023_bib21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4(+) \/CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo","volume":"26","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jisp.2016.10.023_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/pcmr.12284","article-title":"Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation","volume":"27","author":"Eby","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jisp.2016.10.023_bib23","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/jid.2015.26","article-title":"CCL22 to activate Treg migration and suppress depigmentation in vitiligo","volume":"135","author":"Eby","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib24","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1111\/jdv.13340","article-title":"Evaluation of serum trail level and DR4 gene variants as biomarkers for vitiligo patients","volume":"30","author":"Edgunlu","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jisp.2016.10.023_bib25","doi-asserted-by":"crossref","first-page":"18761","DOI":"10.1038\/srep18761","article-title":"Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects","volume":"6","author":"Ganju","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jisp.2016.10.023_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smim.2016.03.019","article-title":"Adoptive T cell transfer: imagining the next generation of cancer immunotherapies","volume":"28","author":"Gattinoni","year":"2016","journal-title":"Seminars Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"59","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib28","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3324\/haematol.2008.001677","article-title":"Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy","volume":"94","author":"Griffioen","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.jisp.2016.10.023_bib29","doi-asserted-by":"crossref","first-page":"e108477","DOI":"10.1371\/journal.pone.0108477","article-title":"Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production","volume":"9","author":"Gonz\u00e1lez-Mateo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jisp.2016.10.023_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsbmb.2010.02.034","article-title":"Immune-modifying properties of topical vitamin D: Focus on dendritic cells and T cells","volume":"121","author":"Gorman","year":"2010","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jisp.2016.10.023_bib31","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.0902778","article-title":"Mechanisms of spatial and temporal development of autoimmune vitiligo in tyrosinase-specific TCR transgenic mice","volume":"184","author":"Gregg","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib32","first-page":"277","article-title":"Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo","volume":"2","author":"Gross","year":"1987","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jisp.2016.10.023_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s12026-012-8267-9","article-title":"Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD","volume":"53","author":"Haase","year":"2012","journal-title":"Immunol Res"},{"issue":"Suppl.","key":"10.1016\/j.jisp.2016.10.023_bib34","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1067\/mjd.2003.274","article-title":"Ethnic skin disorders overview","volume":"48","author":"Halder","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/1346-8138.12978","article-title":"Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata","volume":"42","author":"Han","year":"2015","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib36","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","article-title":"A\u00a0mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin","volume":"132","author":"Harris","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib37","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","article-title":"The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors","volume":"177","author":"Hirahara","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jim.2005.11.023","article-title":"In\u00a0vitro methods for generating CD8+ T-cell clones for immunotherapy from the na\u00efve repertoire","volume":"310","author":"Ho","year":"2006","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jisp.2016.10.023_bib39","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00262-010-0904-3","article-title":"A\u00a0phase I trial of adoptive transfer of allogenic natural killer cells in patients with advanced non-small cell lung cancer","volume":"59","author":"Iliopoulou","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jisp.2016.10.023_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jtbi.2015.07.032","article-title":"Continuum model of T-cell acidity: understanding autoreactive and regulatory T-cell responses in type 1 diabetes","volume":"383","author":"Jaberi-Douraki","year":"2015","journal-title":"J\u00a0Theor Biol"},{"key":"10.1016\/j.jisp.2016.10.023_bib41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1600-0749.2003.00071.x","article-title":"Establishment and characterization of a normal melanocyte cell line derived from pig skin","volume":"16","author":"Jul\u00e9","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.jisp.2016.10.023_bib42","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2174\/1381612821666150428143730","article-title":"Lipid nanoparticles for dermal drug delivery","volume":"21","author":"Kakadia","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jisp.2016.10.023_bib98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5114\/pdia.2016.59507","article-title":"The role of serum vitamin D levels in vitiligo","volume":"33","author":"Karag\u00fcn","year":"2016","journal-title":"Postepy Dermatol Alergol"},{"key":"10.1016\/j.jisp.2016.10.023_bib43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1755-148X.2010.00688.x","article-title":"Reduced skin homing by functional Treg in vitiligo","volume":"23","author":"Klarquist","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jisp.2016.10.023_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/pcmr.12458","article-title":"Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin","volume":"29","author":"Klarquist","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jisp.2016.10.023_bib45","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jisp.2016.10.023_bib46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"(2005). 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A\u00a0review of the worldwide prevalence of vitiligo\u00a0in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib99","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jisp.2016.10.023_bib48","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1523-1747.ep12524353","article-title":"A\u00a0mouse model for vitiligo","volume":"87","author":"Lerner","year":"1986","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib49","first-page":"116","article-title":"(2013). Advances in distinguishing natural from induced Foxp3(+) regulatory T cells","volume":"6","author":"Lin","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jisp.2016.10.023_bib50","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.immuni.2007.11.021","article-title":"A\u00a0two-step process for thymic regulatory T cell development","volume":"28","author":"Lio","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jisp.2016.10.023_bib51","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.4049\/jimmunol.1103271","article-title":"A\u00a0coreceptor- independent transgenic human TCR mediates anti-tumor and anti-self immunity in mice","volume":"189","author":"Mehrotra","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-2427(94)90133-3","article-title":"Sinclair miniature swine: an animal model of human melanoma","volume":"43","author":"Misfeldt","year":"1994","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.jisp.2016.10.023_bib53","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/exd.12885","article-title":"Mechanistic target of rapamycin (mTOR) expression is increased in acne patients\u2019 skin","volume":"25","author":"Monfrecola","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib55","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1158\/1078-0432.CCR-06-0035","article-title":"Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-\/- \u03b3c-\/-immunodeficient mice","volume":"12","author":"Mutis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jisp.2016.10.023_bib56","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/eji.201344381","article-title":"Isolation of human antigen-specific regulatory T cells with high suppressive function","volume":"44","author":"Noyan","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib101","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jisp.2016.10.023_bib57","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/eji.201344280","article-title":"Regulatory T cells in systemic lupus erythematosus","volume":"45","author":"Ohl","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib58","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/1346-8138.12263","article-title":"Role of macrophage infiltration in successful repigmentation in a new periphery-spreading vitiligo lesion in a male Japanese patient","volume":"40","author":"Oiso","year":"2013","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jisp.2016.10.023_bib60","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.autrev.2006.03.012","article-title":"Therapeutic implications of autoimmune vitiligo T cells","volume":"5","author":"Oyarbide-Valencia","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jisp.2016.10.023_bib61","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/eji.200535110","article-title":"Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo","volume":"35","author":"Palermo","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","article-title":"Quality of life in patients with vitiligo","volume":"1","author":"Parsad","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jisp.2016.10.023_bib63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","article-title":"Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases","volume":"12","author":"Perl","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib64","article-title":"\u201cChildhood vitiligo\u201d","author":"Phiske","year":"2016","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.jisp.2016.10.023_bib65","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2307\/2137152","article-title":"Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients","volume":"32","author":"Porter","year":"1991","journal-title":"J\u00a0Health Soc Behav"},{"key":"10.1016\/j.jisp.2016.10.023_bib66","doi-asserted-by":"crossref","first-page":"e74450","DOI":"10.1371\/journal.pone.0074450","article-title":"Beneficial role of rapamycin in experimental autoimmune myositis","volume":"9","author":"Prevel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jisp.2016.10.023_bib67","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jisp.2016.10.023_bib68","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature12199","article-title":"BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis","volume":"498","author":"Roychoudhuri","year":"201327","journal-title":"Nature"},{"key":"10.1016\/j.jisp.2016.10.023_bib69","doi-asserted-by":"crossref","first-page":"e112242","DOI":"10.1371\/journal.pone.0112242","article-title":"BDC12-4.1 T-cell receptor transgenic insulin-specific CD4 T cells are resistant to in\u00a0vitro differentiation into functional Foxp3+ T regulatory cells","volume":"9","author":"Sarikonda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jisp.2016.10.023_bib70","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.0800928105","article-title":"T\u00a0cell receptor signaling controls Foxp3 expression via PI3K Akt mTOR","volume":"105","author":"Sauer","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jisp.2016.10.023_bib71","first-page":"751","article-title":"Sun-exposed skin color is associated with changes in serum 25-Hydroxyvitamin D in racially\/ethnically diverse children","volume":"146","author":"Sawicki","year":"2016","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.jisp.2016.10.023_bib72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00105-015-3751-5","article-title":"Vitiligo: clinical presentation and pathogenesis","volume":"67","author":"Schild","year":"2016","journal-title":"Hautarzt"},{"key":"10.1016\/j.jisp.2016.10.023_bib73","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jcms.2014.06.022","article-title":"Cutaneous and oral squamous cell carcinoma-dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression?","volume":"42","author":"Schipmann","year":"2014","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jisp.2016.10.023_bib74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of Treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib75","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/gutjnl-2012-303635","article-title":"Autoimmune pancreatitis in MRL\/Mp mice is a T cell-mediated disease responsive to cyclosporine A and rapamycin treatment","volume":"63","author":"Schwaiger","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jisp.2016.10.023_bib100","doi-asserted-by":"crossref","first-page":"493213","DOI":"10.1155\/2014\/493213","article-title":"Correlation of vitamin D levels with pigmentation in vitiligo patients treated with NBUVB therapy","volume":"2014","author":"Sehrawat","year":"2014","journal-title":"ISRN Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib76","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1084\/jem.178.4.1231","article-title":"T\u00a0cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in\u00a0vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone","volume":"178","author":"Sensi","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jisp.2016.10.023_bib77","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4274\/jcrpe.2766","article-title":"Investigation the effects of functions of regulatory T cells and vitamin D in children with chronic autoimmune thyroiditis","volume":"8","author":"\u015e\u0131klar","year":"2016","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.jisp.2016.10.023_bib78","doi-asserted-by":"crossref","first-page":"36074","DOI":"10.18632\/oncotarget.8683","article-title":"Defective STAT1 activation associated with impaired IFN-\u03b3 production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2","volume":"7","author":"Sim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jisp.2016.10.023_bib79","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jisp.2016.10.023_bib80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molimm.2014.10.023","article-title":"The immunology of the porcine skin and its value as a model for human skin","volume":"66","author":"Summerfield","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib81","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/bjd.14640","article-title":"Nonsegmental vitiligo disease duration and female sex are associated with comorbidity and disease extent; A retrospective analysis in 1307 patients older than 50 years","volume":"175","author":"Teulings","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib82","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2133.2010.09828.x","article-title":"Vitiligo linked to stigmatization in British South Asian women: a qualitative study of the experiences of living with vitiligo","volume":"163","author":"Thompson","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib83","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00403-011-1154-8","article-title":"Levels of TGF-\u03b2(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo","volume":"303","author":"Tu","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jisp.2016.10.023_bib102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/phpp.12241","article-title":"Low 25-hydroxyvitamin D levels are associated with vitiligo: a systemic review and meta-analysis","volume":"32","author":"Upala","year":"2016","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jisp.2016.10.023_bib84","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","volume":"129","author":"van den Boorn","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jisp.2016.10.023_bib85","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.jisp.2016.10.023_bib103","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaci.2011.01.068","article-title":"Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells","volume":"127","author":"van der Aar","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib86","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.1206803109","article-title":"Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis","volume":"109","author":"van Herwijnen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jisp.2016.10.023_bib87","first-page":"58","article-title":"Disturbed regulatory T cell homeostasis in multiple sclerosis","volume":"16","author":"Venken","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jisp.2016.10.023_bib88","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L","article-title":"Dendritic cells as a major source of macrophage-derived chemokine\/CCL22 in\u00a0vitro and in\u00a0vivo","volume":"31","author":"Vulcano","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2003.09.006","article-title":"Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo","volume":"22","author":"Wang","year":"2004","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jisp.2016.10.023_bib90","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.molonc.2015.11.008","article-title":"Treg depletion in non-human primates using a novel diphtheria toxin-based anti-human CCR4 immunotoxin","volume":"10","author":"Wang","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jisp.2016.10.023_bib91","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.LAB.0000069521.42488.1B","article-title":"Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo","volume":"83","author":"Wa\u0144kowicz-Kali\u0144ska","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.jisp.2016.10.023_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/dth.12176","article-title":"Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis","volume":"28","author":"Wei","year":"2015","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jisp.2016.10.023_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12177","article-title":"The role of T-cell receptor recognition of peptide: MHC complexes in the formation and activity of Foxp3+ regulatory T cells","volume":"259","author":"Weissler","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jisp.2016.10.023_bib93","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/SAP.0b013e31826956f6","article-title":"Transcriptional profiling of rapamycin-treated fibroblasts from hypertrophic and keloid scars","volume":"72","author":"Wong","year":"2014","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jisp.2016.10.023_bib94","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/intimm\/dxm047","article-title":"The maintenance of human regulatory CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in\u00a0vitro","volume":"19","author":"Yates","year":"2007","journal-title":"Int Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib95","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/1744666X.3.3.343","article-title":"Chemokines, chemokine receptors and CD4+CD25+ regulatory T cells","volume":"3","author":"Yi","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jisp.2016.10.023_bib96","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.humimm.2012.05.010","article-title":"Cellular and molecular determinants for the development of natural and induced regulatory T cells","volume":"73","author":"Yuan","year":"2012","journal-title":"Hum Immunol"}],"container-title":["Journal of Investigative Dermatology Symposium Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002416300740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087002416300740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T23:34:29Z","timestamp":1538350469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087002416300740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1087002416300740"],"URL":"https:\/\/doi.org\/10.1016\/j.jisp.2016.10.023","relation":{},"ISSN":["1087-0024"],"issn-type":[{"value":"1087-0024","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replenishing Regulatory T Cells to Halt\u00a0Depigmentation in Vitiligo","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology Symposium Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jisp.2016.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}